Tibet Aim Pharm Inc002826
▲ PositiveCapitalrelevance
Company completed first buyback, signaling confidence, though small scale.

Yiming Pharmaceutical announced that the company has completed its first buyback of 130,000 shares, representing 0.07% of total share capital, with a total buyback amount of 2.23 million yuan and a buyback price range of 17.79 yuan to 17.91 yuan per share. In the first quarter of 2026, Yiming Pharmaceutical achieved revenue of 183 million yuan and net profit attributable to the parent company of 19.65 million yuan.
Tibet Aim Pharm IncCompany completed first buyback, signaling confidence, though small scale.